The next upside target is a steep uptrending Gann angle at $1768.00. Crossing to the strong side of this Gann angle and sustaining the move will put the market in an extremely bullish position....
Fundstrat Global Advisors Managing Partner & Head of Research Tom Lee of joins Yahoo Finance’s Zack Guzman to discuss the market outlook as coronavirus cases in the U.S. surpass 450,000....
Fundstrat Global Advisors Managing Partner & Head of Research Tom Lee of joins Yahoo Finance’s Zack Guzman to discuss the spike in weekly jobless claims and the Fed’s latest COVID-19 rescue plan....
The enormity of the coronavirus pandemic has forced biopharma companies to step up efforts to expeditiously develop vaccines and treatments for COVID-19. The Frontrunners Moderna Inc (NASDAQ: MRNA), which was the first company to move its coronavirus vaccine candidate to the clinics, said in mid-March that the first participant has been dosed in an NIH-led, Phase 1 study of its mRNA vaccine in the U.S.Inovio Pharmaceuticals Inc (NASDAQ: INO) announced earlier this week that it is initiating a Phase 1 study to test its DNA vaccine for the coronavirus following the FDA's acceptance of Inovio's IND application.Apart from these companies, CanSino Biologics and the Academy of Military Sciences are running Phase 1 trials of their non-replicating vaccine candidate in China.The University of Oxford is testing a chimpanzee adeno vector vaccine candidate in a Phase 1/2 trial in the U.K.Novavax, Inc. (NASDAQ: NVAX) said Wednesday it has identified a vaccine candidate and...
Executive Summary: Three weeks ago I predicted that the U.S. death toll from COVID-19 would reach 20,000 by April 15th. In this article I will tell you what you should expect next. Article: I saw this coronavirus pandemic coming back in February. I first warned our premium subscribers and then published a free article on […]...
